Apoptosis-specific EIF-5A and polynucleotides encoding same

The present invention relates to apoptosis specific eucaryotic initiation factor 5A (eIF-5A), referred to as apoptosis-specific eIF-5A or eIF5-A1, nucleic acids and polypeptides and methods for treating sepsis in a mammal by administering siRNA against eIF-5A1 to the mammal.

Saved in:
Bibliographic Details
Main Authors REZNIKOV, LEONID, THOMPSON, JOHN E, TAYLOR, CATHERINE, GALTON, BRUCE C, DINARELLO, CHARLES, HOPKINS, MARIANNE, BOONE, ADRIENNE
Format Patent
LanguageChinese
English
Published 01.10.2006
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to apoptosis specific eucaryotic initiation factor 5A (eIF-5A), referred to as apoptosis-specific eIF-5A or eIF5-A1, nucleic acids and polypeptides and methods for treating sepsis in a mammal by administering siRNA against eIF-5A1 to the mammal.
Bibliography:Application Number: TW200594142843